Practice question

Answer the question and get instant feedback.

Moderate"KDIGO Guideline (2024): Evaluation and Management of CKD"diabetic ckd (finerenone)"diabetic ckd (finerenone)"

A 58-year-old man with CKD G3a A3 and T2D is on ACEI and SGLT2 inhibitor. Potassium 4.6, eGFR 55. Which additional agent is recommended to further reduce renal/CV risk?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.